Member Info for MRK2020

Gino....that has nothing to do with the BOD...except for their intentional? kitchen sinking which created the opportunity.

Thanks Pecten.
I concur, I honestly believe we are one decent PR employee away from a rerate.

dvh - I'm with you..my final top up today. (i've said that before) but making a load of money from one mine, means that this producer and explorer can and should go from strength to strength. lots of other explorers (with better PR etc) are years away from sustainable production.
I'd like to see the company consolidate at BP then push on in 2021/2022 as cash flow improves, and supports costs for other ventures.
I was trying to understand from website and RNS's re the plan for Blueberry Gold project. The website latest is that: “A drilling programme and assaying is underway, which is anticipated to deliver sufficient information to support an Inferred JORC Mineral Resource for gold and other polymetallic minerals including silver, copper, lead and zinc in one or more of several distinct breccia pipes.”
I doubt this is true, but has an update been released?

PS VAST PR team..please update the website

Copper prices quietly ticking up around 3% up. https://markets.businessinsider.com/commodities/copper-price
Out of interest...at what point would the final price be likely to be agreed for the concentrate sales?

To quote Swazers...via the link
Without sounding like a knob Brian, all I pretty much do are charts. I don't have a clue what the companies really do. I have over 200 stocks charted at anyone time. My passion is T.A. I am on a mission to share my charts with the world. Thanks for taking an interest in my stuff.

same here....buy my goodness it's frustrating. accustem and the covid angle were in my well researched view bonus elements, but the market has taken them to be the main drivers. grr.

Decent read this re emergency use of eli lily monoclonal antibody.

https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-monoclonal-antibody-treatment-covid-19

this US gap...do we think we will go down to them or they go up to us..? surely the latter looking at the prices

So the proactive write up this week asks..
Should a company that’s potentially capable of generating more than US$70mln in revenues per year by the end of 2021 still be valued at just under £25mln.. .

So the punt is the same... Does a short boat delay really matter in longer term... Gla

This RNS would have been fantastic... If it came after the sale confirmation.
Is the concentrate at port already... I wondered if there was a boat delay then perhaps an opportunity to further boost the size of the sale by upping the quantity.

Just a quick message to say a very constructive and insightful discussion since Friday in light of the RNS.
It's been helpful, and in my case I am much more confident in my initial views (onwards and upwards based on a bottom line that, irrespective of the parties involved, VAST have negotiated a decent trade in light of the assets secured).
Time will tell, so will sit back next few weeks and watch how this plays out.

Plus from a corporate perspective this makes the company much more investible in future...hence being a condition of the financing

Such a shame that this was communicated in the way that it was... Because I'm coming around to this being great news. Full ownership... Addressing the messy 20%...interests aligned.. Other assets thrown in.
Now, imagine if there had just been up front acknowledgement of this, would have read very differently. That said it is indeed very messy, and various conflicts of interest, so cest la vie...
Overall, bottom line... Great development in unison with finance

Putting aside some of the frustrations re timing, placing...and publicity in run up... It's at least good that we've gained the 20% hopefully for all shareholder benefit. Next week will be interesting.

Ben...you mention 6 months...pretty much when I put first order in at .16/17 in think.
It's kind of frustrating that VAST and BP have made momentous progress in those 6 months..and nothing in the SP to show for it. As in, it was a hell of a lot more of a risky buy, then than for those that will undoubtedly take positions in the next few weeks/months. But anyhow good luck to new and old investors alike. It's a nice time to have a mine.
and have a good weekend all

newtrade...can't argue with that.
it's all about the balance of risk and potential reward. Riskier this week, but if all comes off, should be higher price next week.
Just noticed the advert on banner at top of LSE..will be interesting to see if brings traffic...a hell of a lot of people will see the ad (if not the video!)
Vast Resources CEO Andrew Prelea celebrates the first sale of copper concentrate from Romanian mine Watch Now
Anyways, back to work. GLA.

Sorry wrong board so doubt it'll bring traffic here ha.

Just noticed the advert at top of page..
Vast Resources CEO Andrew Prelea celebrates the first sale of copper concentrate from Romanian mine Watch Now
Will be interesting to see if that brings traffic this afternoon.

I'm scratching my head a bit at the lack of interest in what seems a really good opportunity here (IMO).
I agree Max on the brightside, re chance to top up and bring my average down. I'm already fully committed here though...albeit that I thought Sarah was too (before this morning) lol.
You'll need the extra income Sarah for the Porshe fuel.

Re confidentiality there may not be a specific clause per se in place with the clinical trials team; as the issue of results relates to good clinical practice as well as confidentiality. i.e. it would be unethical to relay any results prior to analysis and scientific scrutiny from the investigative team. Furthermore, very few people will have access to the overall data as it comes in.
Re follow-up period...it would be all well and good if there are good clinical outcomes in the first few days; but no use if 2 weeks later everyone is dead!. I'm not saying that would happen here but my point is that it would be good to know what the follow up period is for the study. I would guess at a month. If anyone digs out a protocol or outline of the study please let us know.
I work in a clinical trials unit btw.